PUBLISHER: IMARC | PRODUCT CODE: 1541630
PUBLISHER: IMARC | PRODUCT CODE: 1541630
Digital Therapeutics Market Report by Application (Diabetes, Obesity, CVD, CNS Disease, Respiratory Diseases, Smoking Cessation, and Others), End Use (Patients, Providers, Payers, Employers, and Others), and Region 2024-2032
The global digital therapeutics market size reached US$ 6.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 26.8 Billion by 2032, exhibiting a growth rate (CAGR) of 17.5% during 2024-2032. The growing demand for digital behavior-monitoring treatment, increasing prevalence of chronic diseases, and rising awareness among the masses about personal health and fitness represent one of the key factors driving the market.
Increasing Usage of Smartphones and Tablets Propelling Market Growth
The rising reliance on smartphones and tablets, coupled with different healthcare apps, is propelling the growth of the digital therapeutics market. Smartphones and tablet-based healthcare apps have numerous advantages over the lower rate of medication errors, facilitating preventive care, and more accurate staffing. The increasing utilization of personal technological devices in healthcare is catalyzing the demand for digital therapeutics (DTx) treatments. DTx is enhancing patient access to the safety and effectiveness of treatments, presenting information in different languages, providing relevant information about diseases and treatments, and expanding the ability of physicians to care for patients. Furthermore, it is an advanced mode of care delivery, which can be easily implemented at home and eliminates any stigma associated with traditional therapies.
Digital Therapeutics Market Trends:
Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. The market structure is moderately fragmented with the presence of a large number of global and regional players. Moreover, the competitive environment in this market is intensifying due to the increasing number of research and development (R&D) innovations and mergers and acquisitions (M&A). The volume of new entrants is moderate in the digital therapeutics industry due to the fragmented market structure and low product differentiation and switching cost. In addition, the growing number of mhealth developers is contributing to the high threat of new entrants. However, the requirement of patents and high costs of advanced technologies along with stringent regulatory procedures, decreases the threat from new entrants.
What are Digital Therapeutics?
Digital therapeutics (DTx) is an evidence-based therapeutic intervention driven by high-quality software programs to prevent, manage, or treat a medical disorder or disease. It is a form of a software-as-a-medical device (SaMD) that relies on software interventions to bring about behavioral changes in patients and help treat their conditions. DTx is a fast-emerging class of therapies that utilizes software to treat disease as a standalone or for treatment optimization. It assists in preventing and managing a wide variety of diseases and conditions, such as type 2 diabetes, congestive heart failure, obesity, Alzheimer's disease, dementia, asthma, substance abuse, attention deficit hyperactivity disorder (ADHD), hypertension, anxiety, depression, and several others. DTx also aids in improving patient medication adherence and supporting healthcare professionals (HCPs) to manage their patients and businesses digitally.
COVID-19 Impact:
The arrival of the COVID-19 pandemic can be described as a watershed moment for the healthcare industry. It changed the manner of healthcare delivery dramatically while exposing the lack of preparedness on the part of governments worldwide to adequately tackle a global healthcare emergency. Frontline health workers were involved in managing COVID-19 patients, but patients with other health conditions, especially chronic health conditions, experienced difficulties as their in-clinic visits were postponed or avoided. Moreover, as the outcomes of COVID-19 among patients with comorbidities, especially obesity, heart complications, and diabetes, were worse than those without, these patients were asked to be additionally vigilant. The pandemic also brought a fair share of mental health disorders, including depression, anxiety, and withdrawals, and their management was a challenge due to the lack of face-to-face visits. These interconnected events have made healthcare providers look out for digital health solutions to tackle health crisis. There was a positive trend observed during the COVID-19 outbreak in relation to the adoption of digital health technologies, which increased the efficiency and effectiveness of healthcare operations and service delivery. After the pandemic started, the adoption of DTx applications in various fields accelerated many folds. Additionally, the COVID-19 pandemic increased the adoption of virtual and home care technologies by transforming patient engagement and integrating data across the healthcare landscape.
Digital Therapeutics Market Trends:
At present, there is a rise in the demand for DTx among type 2 diabetes patients to manage the disease and enable them to use the internet of things (IoT)-enabled insulin pumps and other health monitoring systems. This, along with the increasing demand for digital behavior-monitoring treatment to ensure medication adherence and healthy lifestyle changes, represents one of the key factors supporting the growth of the market. In addition, the growing utilization of DTx to reduce the need for more follow-up checkups and relapses compared to traditional treatments is offering a favorable market outlook. Moreover, there is an increase in the prevalence of chronic diseases, such as heart disease, stroke, cancer, obesity, and arthritis. This, coupled with the rising awareness among the masses about personal health and fitness, is propelling the growth of the market. Additionally, the escalating demand for DTx to help doctors manage patient adherence to medical regimens and build an integrated health ecosystem that can enable the seamless transfer of data between different stakeholders, such as payers, providers, and pharmacies, is bolstering the growth of the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global digital therapeutics market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on application and end use.
Application Insights:
Diabetes
Obesity
CVD
CNS Disease
Respiratory Diseases
Smoking Cessation
Others
The report has provided a detailed breakup and analysis of the digital therapeutics market based on the application. This includes diabetes, obesity, CVD, CNS disease, respiratory diseases, smoking cessation, and others. According to the report, diabetes represented the largest segment due to the rising prevalence of diabetes, along with the high risk of associated conditions, such as cardiac arrests, kidney failure, and blindness, in diabetic patients. Moreover, the growing integration of DTx with numerous medical devices, such as insulin pumps, glucose blood meters, and wearable gadgets, is positively influencing the market.
End Use Insights:
Patients
Providers
Payers
Employers
Others
A detailed breakup and analysis of the digital therapeutics market based on the end use has also been provided in the report. This includes patients, providers, payers, employers, and others. According to the report, patients accounted for the largest market share due to the rising adoption of DTx among patients for numerous associated benefits pertaining to elective health management at an affordable cost. In addition, the increasing consumer inclination towards patient management systems for improving retention and compliance with post hospitalization follow-up visits is catalyzing the demand for DTx.
Regional Insights:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America (the United States and Canada) was the largest market for digital therapeutics. Some of the factors driving the North America digital therapeutics market included the growing geriatric population, continuous upgradations in drug approval processes by the Food and Drug Administration (FDA), rising awareness about the benefits of DTx, etc. In addition, the growing utilization of DTx as a standalone therapy or in conjunction with medications, devices, and other therapies to optimize patient care and healthcare outcomes is offering a favorable market outlook.
Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global digital therapeutics market. Some of the companies covered in the report include:
2Morrow Inc.
Canary Health Inc.
Click Therapeutics Inc.
Mango Health Inc. (TrialCard Incorporated)
Noom Health Inc.
Omada Health Inc.
Pear Therapeutics, Inc.
Propeller Health (ResMed)
Teladoc Health Inc.
Voluntis Inc.
WellDoc Inc.
Please note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Questions Answered in This Report
- 1. What was the size of the global digital therapeutics market in 2023?
- 2. What is the expected growth rate of the global digital therapeutics market during 2024-2032?
- 3. What are the key factors driving the global digital therapeutics market?
- 4. What has been the impact of COVID-19 on the global digital therapeutics market?
- 5. What is the breakup of the global digital therapeutics market based on the application?
- 6. What is the breakup of the global digital therapeutics market based on the end use?
- 7. What are the key regions in the global digital therapeutics market?
- 8. Who are the key players/companies in the global digital therapeutics market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Digital Therapeutics Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Application
- 6.1 Diabetes
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Obesity
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 CVD
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 CNS Disease
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
- 6.5 Respiratory Diseases
- 6.5.1 Market Trends
- 6.5.2 Market Forecast
- 6.6 Smoking Cessation
- 6.6.1 Market Trends
- 6.6.2 Market Forecast
- 6.7 Others
- 6.7.1 Market Trends
- 6.7.2 Market Forecast
7 Market Breakup by End Use
- 7.1 Patients
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Providers
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Payers
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Employers
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 Others
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
8 Market Breakup by Region
- 8.1 North America
- 8.1.1 United States
- 8.1.1.1 Market Trends
- 8.1.1.2 Market Forecast
- 8.1.2 Canada
- 8.1.2.1 Market Trends
- 8.1.2.2 Market Forecast
- 8.1.1 United States
- 8.2 Asia-Pacific
- 8.2.1 China
- 8.2.1.1 Market Trends
- 8.2.1.2 Market Forecast
- 8.2.2 Japan
- 8.2.2.1 Market Trends
- 8.2.2.2 Market Forecast
- 8.2.3 India
- 8.2.3.1 Market Trends
- 8.2.3.2 Market Forecast
- 8.2.4 South Korea
- 8.2.4.1 Market Trends
- 8.2.4.2 Market Forecast
- 8.2.5 Australia
- 8.2.5.1 Market Trends
- 8.2.5.2 Market Forecast
- 8.2.6 Indonesia
- 8.2.6.1 Market Trends
- 8.2.6.2 Market Forecast
- 8.2.7 Others
- 8.2.7.1 Market Trends
- 8.2.7.2 Market Forecast
- 8.2.1 China
- 8.3 Europe
- 8.3.1 Germany
- 8.3.1.1 Market Trends
- 8.3.1.2 Market Forecast
- 8.3.2 France
- 8.3.2.1 Market Trends
- 8.3.2.2 Market Forecast
- 8.3.3 United Kingdom
- 8.3.3.1 Market Trends
- 8.3.3.2 Market Forecast
- 8.3.4 Italy
- 8.3.4.1 Market Trends
- 8.3.4.2 Market Forecast
- 8.3.5 Spain
- 8.3.5.1 Market Trends
- 8.3.5.2 Market Forecast
- 8.3.6 Russia
- 8.3.6.1 Market Trends
- 8.3.6.2 Market Forecast
- 8.3.7 Others
- 8.3.7.1 Market Trends
- 8.3.7.2 Market Forecast
- 8.3.1 Germany
- 8.4 Latin America
- 8.4.1 Brazil
- 8.4.1.1 Market Trends
- 8.4.1.2 Market Forecast
- 8.4.2 Mexico
- 8.4.2.1 Market Trends
- 8.4.2.2 Market Forecast
- 8.4.3 Others
- 8.4.3.1 Market Trends
- 8.4.3.2 Market Forecast
- 8.4.1 Brazil
- 8.5 Middle East and Africa
- 8.5.1 Market Trends
- 8.5.2 Market Breakup by Country
- 8.5.3 Market Forecast
9 SWOT Analysis
- 9.1 Overview
- 9.2 Strengths
- 9.3 Weaknesses
- 9.4 Opportunities
- 9.5 Threats
10 Value Chain Analysis
11 Porters Five Forces Analysis
- 11.1 Overview
- 11.2 Bargaining Power of Buyers
- 11.3 Bargaining Power of Suppliers
- 11.4 Degree of Competition
- 11.5 Threat of New Entrants
- 11.6 Threat of Substitutes
12 Price Analysis
13 Competitive Landscape
- 13.1 Market Structure
- 13.2 Key Players
- 13.3 Profiles of Key Players
- 13.3.1 2Morrow Inc.
- 13.3.1.1 Company Overview
- 13.3.1.2 Product Portfolio
- 13.3.2 Canary Health Inc.
- 13.3.2.1 Company Overview
- 13.3.2.2 Product Portfolio
- 13.3.3 Click Therapeutics Inc.
- 13.3.3.1 Company Overview
- 13.3.3.2 Product Portfolio
- 13.3.4 Mango Health Inc. (TrialCard Incorporated)
- 13.3.4.1 Company Overview
- 13.3.4.2 Product Portfolio
- 13.3.5 Noom Health Inc.
- 13.3.5.1 Company Overview
- 13.3.5.2 Product Portfolio
- 13.3.6 Omada Health Inc.
- 13.3.6.1 Company Overview
- 13.3.6.2 Product Portfolio
- 13.3.7 Pear Therapeutics, Inc.
- 13.3.7.1 Company Overview
- 13.3.7.2 Product Portfolio
- 13.3.8 Propeller Health (ResMed)
- 13.3.8.1 Company Overview
- 13.3.8.2 Product Portfolio
- 13.3.9 Teladoc Health Inc.
- 13.3.9.1 Company Overview
- 13.3.9.2 Product Portfolio
- 13.3.10 Voluntis Inc.
- 13.3.10.1 Company Overview
- 13.3.10.2 Product Portfolio
- 13.3.11 WellDoc Inc.
- 13.3.11.1 Company Overview
- 13.3.11.2 Product Portfolio
- 13.3.1 2Morrow Inc.
List of Figures
- Figure 1: Global: Digital Therapeutics Market: Major Drivers and Challenges
- Figure 2: Global: Digital Therapeutics Market: Sales Value (in Billion US$), 2018-2023
- Figure 3: Global: Digital Therapeutics Market Forecast: Sales Value (in Billion US$), 2024-2032
- Figure 4: Global: Digital Therapeutics Market: Breakup by Application (in %), 2023
- Figure 5: Global: Digital Therapeutics Market: Breakup by End Use (in %), 2023
- Figure 6: Global: Digital Therapeutics Market: Breakup by Region (in %), 2023
- Figure 7: Global: Digital Therapeutics (Diabetes) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 8: Global: Digital Therapeutics (Diabetes) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 9: Global: Digital Therapeutics (Obesity) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 10: Global: Digital Therapeutics (Obesity) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 11: Global: Digital Therapeutics (CVD) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 12: Global: Digital Therapeutics (CVD) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 13: Global: Digital Therapeutics (CNS Disease) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 14: Global: Digital Therapeutics (CNS Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 15: Global: Digital Therapeutics (Respiratory Diseases) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 16: Global: Digital Therapeutics (Respiratory Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 17: Global: Digital Therapeutics (Smoking Cessation) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 18: Global: Digital Therapeutics (Smoking Cessation) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 19: Global: Digital Therapeutics (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 20: Global: Digital Therapeutics (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 21: Global: Digital Therapeutics (Patients) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 22: Global: Digital Therapeutics (Patients) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 23: Global: Digital Therapeutics (Providers) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 24: Global: Digital Therapeutics (Providers) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 25: Global: Digital Therapeutics (Payers) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 26: Global: Digital Therapeutics (Payers) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 27: Global: Digital Therapeutics (Employers) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 28: Global: Digital Therapeutics (Employers) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 29: Global: Digital Therapeutics (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 30: Global: Digital Therapeutics (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 31: North America: Digital Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 32: North America: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 33: United States: Digital Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 34: United States: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 35: Canada: Digital Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 36: Canada: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 37: Asia-Pacific: Digital Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 38: Asia-Pacific: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 39: China: Digital Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 40: China: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 41: Japan: Digital Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 42: Japan: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 43: India: Digital Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 44: India: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 45: South Korea: Digital Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 46: South Korea: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 47: Australia: Digital Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 48: Australia: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 49: Indonesia: Digital Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 50: Indonesia: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 51: Others: Digital Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 52: Others: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 53: Europe: Digital Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 54: Europe: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 55: Germany: Digital Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 56: Germany: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 57: France: Digital Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 58: France: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 59: United Kingdom: Digital Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 60: United Kingdom: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 61: Italy: Digital Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 62: Italy: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 63: Spain: Digital Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 64: Spain: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 65: Russia: Digital Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 66: Russia: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 67: Others: Digital Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 68: Others: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 69: Latin America: Digital Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 70: Latin America: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 71: Brazil: Digital Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 72: Brazil: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 73: Mexico: Digital Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 74: Mexico: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 75: Others: Digital Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 76: Others: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 77: Middle East and Africa: Digital Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 78: Middle East and Africa: Digital Therapeutics Market: Breakup by Country (in %), 2023
- Figure 79: Middle East and Africa: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 80: Global: Digital Therapeutics Industry: SWOT Analysis
- Figure 81: Global: Digital Therapeutics Industry: Value Chain Analysis
- Figure 82: Global: Digital Therapeutics Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Digital Therapeutics Market: Key Industry Highlights, 2023 and 2032
- Table 2: Global: Digital Therapeutics Market Forecast: Breakup by Application (in Million US$), 2024-2032
- Table 3: Global: Digital Therapeutics Market Forecast: Breakup by End Use (in Million US$), 2024-2032
- Table 4: Global: Digital Therapeutics Market Forecast: Breakup by Region (in Million US$), 2024-2032
- Table 5: Global: Digital Therapeutics Market: Competitive Structure
- Table 6: Global: Digital Therapeutics Market: Key Players
